Multiverse Computing's CompactifAI technology shrinks Llama AI models by 80%, boosting efficiency with 60% fewer parameters, 84% greater energy efficiency, 40% faster inference, and 50% cost reduction, enabling new use cases for portable AI.
Ex-Google AI Chief Ilya Sutskever's startup Safe Superintelligence (SSI), backed by $1 billion, is tapping Google Cloud's powerful TPU chips in its quest to develop safe, superintelligent AI systems, marking another AI computing deal between Google and a former employee's startup.
Google's Ironwood AI processor, designed for its Gemini AI models and simulated reasoning, unleashes an astounding 42.5 Exaflops of computing power through clusters of up to 9,216 liquid-cooled chips with enhanced interconnect, surpassing previous Google TPUs in speed and efficiency.
CompactifAI unveils LLaMA 3.3 70B Slim, a compressed AI model 80% smaller, 2.18x faster, with near-perfect accuracy, enabling edge deployment, lower energy consumption, and secure enterprise AI solutions while maintaining industry-leading performance.
AI agents' energy usage varies based on model size, modality, and output length, necessitating a balance between performance and sustainability through efficient model selection, open-source frameworks, and task-appropriate approaches.
IBM has launched the z17 mainframe, engineered specifically for AI and generative AI workloads, featuring high-capacity Telum II processors, compatibility with IBM's Spyre accelerator chips, and new performance management and operating system tools.
Meta unveils Llama 4 Behemoth, one of the most powerful multimodal AI language models, as part of its Llama 4 release, reinforcing its massive investment in AI with plans to spend up to $65 billion by 2025.
SoftBank Group plans to invest up to $40 billion in OpenAI, with $10 billion upfront and up to $30 billion more by 2026, to support OpenAI's quest for Artificial General Intelligence and ultimately Artificial Super Intelligence for the advancement of humanity.
Google-backed AI drug discovery startup Isomorphic Labs secured a staggering $600 million in funding led by Thrive Capital, fueling its AI engine's development and advancing partnerships with pharmaceutical giants like Eli Lilly and Novartis worth billions to revolutionize drug design.
Alphabet's AI drug discovery subsidiary Isomorphic Labs secures $600 million funding from Thrive Capital to accelerate development of its AI-powered drug design platform and advance its drug candidates into clinical trials, leveraging technology like DeepMind's AlphaFold.